United States Pharmaceuticals

Fortress Biotech Inc (FBIO)

Track

Fortress Biotech Inc. has seen no insider trading activity within the last three months. The most recent transaction occurred on September 23, 2024, when CEO Lindsay A. Rosenwald purchased 763,359 shares. Prior to this, the company experienced a series of insider buying activities throughout 2024, primarily led by executive leadership.
Ticker: FBIO Exchange: NAS
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Upgrade for signal details

Upgrade to see score, net flow, insiders and context.

Upgrade to see full signal details →

Insider trades have triggered activity signals for Fortress Biotech Inc. Upgrade to see score, net flow, insiders and the full signal context.

Open in Activity Signals screener →
Top insiders
Trades
Buy 23 Sep 2024
Value US$4,696,759.40 | Price 18.52 | Shares 17,107 (-22.8%)
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2024-09-25 2024-09-23 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
17,107 -22.8%
18.52
US$4,696,759 		17,107 -22.8% 18.52 US$4,696,759
2024-07-15 2024-07-11 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
42,092 -39.4%
143.09
US$1,599,033 		42,092 -39.4% 143.09 US$1,599,033
2024-07-12 2024-07-10 B Purchase
1.3
Jin David

Chief Financial Officer

Officer
33,788 -47.2%
312.61
US$3,563,978 		33,788 -47.2% 312.61 US$3,563,978
2024-07-11 2024-07-09 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
5,000 +4.3%
7.39
US$36,971 		5,000 +4.3% 7.39 US$36,971
2024-07-10 2024-07-08 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
5,000 +4.4%
7.35
US$36,764 		5,000 +4.4% 7.35 US$36,764
2024-07-01 2024-06-28 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
20,000 +0.7%
1.64
US$32,724 		20,000 +0.7% 1.64 US$32,724
2024-05-20 2024-05-20 S Sale
1.8
Klein Dov
Non-Executive Director
10,000 -15.8%
1.89
US$18,900 		10,000 -15.8% 1.89 US$18,900
2024-05-17 2024-05-20 PrS Proposed sale
1.8
Klein Dov

Director

Non-Executive Director
10,000
1.76
US$17,600 		10,000 1.76 US$17,600
2024-05-20 2024-05-16 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +0.3%
1.76
US$17,589 		10,000 +0.3% 1.76 US$17,589
2024-05-20 2024-05-16 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +0.3%
1.76
US$17,589 		10,000 +0.3% 1.76 US$17,589
2024-01-09 2024-01-05 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
50,000 +1.8%
2.38
US$118,770 		50,000 +1.8% 2.38 US$118,770
2023-11-16 2023-11-14 B Purchase
3.8
WEISS MICHAEL S

See Remarks

Executive Director
147,058 +15.0%
1.70
US$249,999 		147,058 +15.0% 1.70 US$249,999
2023-11-16 2023-11-14 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
1,567,515 +152.2%
1.70
US$2,664,776 		1,567,515 +152.2% 1.70 US$2,664,776
2023-09-27 2023-09-26 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
100,000 +0.7%
0.28
US$28,330 		100,000 +0.7% 0.28 US$28,330
2023-08-21 2023-08-18 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +9.8%
9.34
US$93,400 		10,000 +9.8% 9.34 US$93,400
2023-08-21 2023-08-17 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
10,000 +10.8%
11.75
US$117,500 		10,000 +10.8% 11.75 US$117,500
2023-02-14 2023-02-10 B Purchase
3.9
ROSENWALD LINDSAY A MD

President, CEO & Chairman

Executive Director Large shareholder
2,395,209 +18.5%
0.84
US$2,000,000 		2,395,209 +18.5% 0.84 US$2,000,000
2023-02-14 2023-02-10 B Purchase
2.8
Rowinsky Eric K
Non-Executive Director
11,976 +1.3%
0.84
US$10,000 		11,976 +1.3% 0.84 US$10,000
2023-02-14 2023-02-10 B Purchase
LOBELL J JAY
Non-Executive Director
299,401 +22.4%
0.84
US$250,000 		299,401 +22.4% 0.84 US$250,000
2023-02-14 2023-02-10 B Purchase
Lu Lucy
Non-Executive Director
11,976 +9.9%
0.84
US$10,000 		11,976 +9.9% 0.84 US$10,000
2023-02-14 2023-02-10 B Purchase
1.3
Jin David

Chief Financial Officer

Officer
35,928 +2.6%
0.84
US$30,000 		35,928 +2.6% 0.84 US$30,000
2023-02-14 2023-02-10 B Purchase
3.8
WEISS MICHAEL S

See Remarks

Executive Director Large shareholder
1,197,604 +8.8%
0.84
US$999,999 		1,197,604 +8.8% 0.84 US$999,999
2022-12-05 2022-12-01 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
100,000 +0.9%
0.68
US$67,960 		100,000 +0.9% 0.68 US$67,960
2022-12-02 2022-11-30 PP Planned purchase
1.3
Jin David

Chief Financial Officer

Officer
5,000 +0.4%
0.56
US$2,800 		5,000 +0.4% 0.56 US$2,800
2022-12-02 2022-11-30 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
5,000 +0.0%
0.56
US$2,800 		5,000 +0.0% 0.56 US$2,800
2022-10-24 2022-10-21 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
100,000 +0.9%
0.70
US$69,500 		100,000 +0.9% 0.70 US$69,500
2022-04-29 2021-12-28 S Sale
1.8
Klein Dov
Non-Executive Director
5,000 -0.8%
2.45
US$12,250 		5,000 -0.8% 2.45 US$12,250
2022-04-29 2021-09-21 S Sale
Hunter Robyn

Chief Financial Officer

Officer
28,292 -14.7%
3.13
US$88,554 		28,292 -14.7% 3.13 US$88,554
2021-04-09 2021-03-02 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
10,000 -1.4%
4.45
US$44,500 		10,000 -1.4% 4.45 US$44,500
2021-04-09 2021-02-19 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
8,000 -1.1%
4.31
US$34,480 		8,000 -1.1% 4.31 US$34,480
2021-04-09 2021-02-18 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
6,000 -0.8%
4.20
US$25,200 		6,000 -0.8% 4.20 US$25,200
2021-04-09 2021-02-16 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
2,000 -0.3%
3.86
US$7,720 		2,000 -0.3% 3.86 US$7,720
2021-04-09 2021-02-05 S Sale
2.8
Rowinsky Eric K
Non-Executive Director
4,000 -0.5%
3.80
US$15,200 		4,000 -0.5% 3.80 US$15,200
2021-04-09 2021-01-01 B Purchase
Lorenz Kevin
Non-Executive Director
50,000
0.00
US$0 		50,000 0.00 US$0
2020-09-25 2020-09-22 S Sale
Hunter Robyn

Chief Financial Officer

Officer
28,450 -12.9%
4.38
US$124,611 		28,450 -12.9% 4.38 US$124,611
2020-09-01 2020-08-26 B Purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
52,500 +131.2%
18.00
US$945,000 		52,500 +131.2% 18.00 US$945,000
2020-09-01 2020-08-26 B Purchase
Hoenlein Malcolm
Non-Executive Director
16,667 +inf%
18.00
US$300,006 		16,667 +inf% 18.00 US$300,006
2020-03-13 2020-01-01 B Purchase
Lorenz Kevin
50,000
0.00
US$0 		50,000 0.00 US$0
2020-03-13 2019-12-01 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
1,123 +0.0%
2.06
US$2,313 		1,123 +0.0% 2.06 US$2,313
2020-03-13 2019-06-03 PP Planned purchase
3.9
ROSENWALD LINDSAY A MD

PRESIDENT, CEO & CHAIRMAN

Executive Director Large shareholder
1,467 +0.0%
1.10
US$1,614 		1,467 +0.0% 1.10 US$1,614
2019-12-31 2019-06-03 PP Planned purchase
Hunter Robyn

Chief Financial Officer

Officer
2,297 +1.1%
1.10
US$2,527 		2,297 +1.1% 1.10 US$2,527
2018-12-13 2018-12-11 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS

Officer
97,325 -27.6%
1.05
US$102,191 		97,325 -27.6% 1.05 US$102,191
2018-11-30 2018-11-23 S Sale Hunter Robyn

Chief Financial Officer

Officer
20,370 -7.8%
1.29
US$26,277 		20,370 -7.8% 1.29 US$26,277
2017-12-18 2017-12-14 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS
12,000 -3.3%
3.55
US$42,600 		12,000 -3.3% 3.55 US$42,600
2017-12-14 2017-12-13 S Sale
Avgerinos George

SVP, BIOLOGICS OPERATIONS
19,000 -5.0%
3.57
US$67,830 		19,000 -5.0% 3.57 US$67,830
2017-12-14 2017-12-12 S Sale Avgerinos George

SVP, BIOLOGICS OPERATIONS
25,593 -6.3%
3.59
US$91,879 		25,593 -6.3% 3.59 US$91,879
2017-11-08 2017-11-06 B Purchase ROSENWALD LINDSAY A MD

PRESIDENT, CEO

Executive Director Large shareholder
40,000 +inf%
25.00
US$1,000,000 		40,000 +inf% 25.00 US$1,000,000
2017-01-27 2016-12-01 PP Planned purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
731 +0.0%
2.03
US$1,484 		731 +0.0% 2.03 US$1,484
2016-09-19 2016-09-16 S Sale Avgerinos George

SVP, Biologics Operations

Officer
33,912 -11.6%
2.55
US$86,476 		33,912 -11.6% 2.55 US$86,476
2016-09-19 2016-09-15 S Sale Avgerinos George

SVP, Biologics Operations

Officer
15,000 -4.9%
2.54
US$38,100 		15,000 -4.9% 2.54 US$38,100
2016-06-17 2016-06-01 PP Planned purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
613 +0.0%
2.40
US$1,471 		613 +0.0% 2.40 US$1,471
2014-11-10 2014-11-06 B Purchase ROSENWALD LINDSAY A MD

President and CEO

Executive Director Large shareholder
150,000 +3.2%
1.61
US$241,500 		150,000 +3.2% 1.61 US$241,500
2014-11-10 2014-11-06 B Purchase
Hoenlein Malcolm
Non-Executive Director
25,000 +83.3%
1.61
US$40,250 		25,000 +83.3% 1.61 US$40,250
2014-11-10 2014-11-06 B Purchase
3.8
WEISS MICHAEL S

Exec. VC - Strategic Dev.

Executive Director Large shareholder
1,000,000 +16.8%
1.61
US$1,610,000 		1,000,000 +16.8% 1.61 US$1,610,000
2014-04-23 2014-04-22 S Sale
HORGAN KEVIN

Former Chief Medical Officer
47,566 -100.0%
1.89
US$89,976 		47,566 -100.0% 1.89 US$89,976
2014-04-22 2014-04-21 S Sale
HORGAN KEVIN

Former Chief Medical Officer
19,000 -100.0%
1.81
US$34,382 		19,000 -100.0% 1.81 US$34,382
2014-04-21 2014-04-17 S Sale
HORGAN KEVIN

Former Chief Medical Officer
101 -100.0%
1.85
US$187 		101 -100.0% 1.85 US$187
2013-08-22 2013-08-21 B Purchase
LOBELL J JAY
Non-Executive Director
5,000 +1.5%
7.37
US$36,850 		5,000 +1.5% 7.37 US$36,850
2013-08-22 2013-08-21 B Purchase
Lu Lucy

Chief Financial Officer

Officer
5,000 +25.6%
7.38
US$36,900 		5,000 +25.6% 7.38 US$36,900
2013-07-18 2013-07-17 B Purchase Lu Lucy

Chief Financial Officer

Officer
4,545 +30.3%
7.90
US$35,906 		4,545 +30.3% 7.90 US$35,906
2013-06-21 2013-06-20 B Purchase
LOBELL J JAY
Non-Executive Director
10,000 +3.1%
7.62
US$76,231 		10,000 +3.1% 7.62 US$76,231
2013-06-21 2013-06-20 B Purchase
Weisman Harlan F

Chairman and CEO

Executive Director
10,000 +50.0%
7.59
US$75,900 		10,000 +50.0% 7.59 US$75,900
2013-01-15 2013-01-14 B Purchase
Weisman Harlan F

Chairman and CEO

Executive Director
20,000 +inf%
5.71
US$114,200 		20,000 +inf% 5.71 US$114,200
2012-06-26 2012-06-22 B Purchase
LOBELL J JAY
Non-Executive Director
25,000 +8.4%
5.00
US$125,000 		25,000 +8.4% 5.00 US$125,000
2012-06-26 2012-06-22 B Purchase
Lu Lucy

Chief Financial Officer

Officer
10,000 +inf%
5.00
US$50,000 		10,000 +inf% 5.00 US$50,000
2012-06-26 2012-06-22 B Purchase RITTER DALE

SVP & Chief Accounting Officer

Officer
5,000 +100.0%
5.00
US$25,000 		5,000 +100.0% 5.00 US$25,000
2012-06-26 2012-06-22 B Purchase SANDAGE BOBBY W PHD

President and CEO

Executive Director
10,000 +87.0%
5.00
US$50,000 		10,000 +87.0% 5.00 US$50,000
2012-06-26 2012-06-22 B Purchase COOPER GLENN L MD

See Remarks

Executive Director
10,000 +33.3%
5.30
US$52,968 		10,000 +33.3% 5.30 US$52,968
2012-06-26 2012-06-22 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
200,000 +8.1%
5.00
US$1,000,000 		200,000 +8.1% 5.00 US$1,000,000
2012-06-26 2012-06-22 B Purchase
Hehenberger Karin M.

See Remarks

Officer
20,000 +2162.2%
5.00
US$100,000 		20,000 +2162.2% 5.00 US$100,000
2012-06-26 2012-06-22 B Purchase
Beerman Noah D

EVP & COO

Officer
5,000 +100.0%
5.00
US$25,000 		5,000 +100.0% 5.00 US$25,000
2012-01-23 2012-01-23 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
6.95
US$13,900 		2,000 +0.1% 6.95 US$13,900
2012-01-20 2012-01-20 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.66
US$11,320 		2,000 +0.1% 5.66 US$11,320
2012-01-19 2012-01-19 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.67
US$11,340 		2,000 +0.1% 5.67 US$11,340
2012-01-18 2012-01-18 B Purchase ROSENWALD LINDSAY A MD Non-Executive Director Large shareholder
2,000 +0.1%
5.66
US$11,320 		2,000 +0.1% 5.66 US$11,320
Explore more

More insider trading research around Fortress Biotech Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Pharmaceuticals companies with insider activity
Insider trading in North America